2024 | At present there is no approved evidence base for the use of this treatment and no real clarity as to which of those with Long COVID would benefit from the treatment
Apheresis refers to the process of separating the cellular and soluble components of blood using a machine.
Summary:
Dec 18, 2023 | There are now at least 65 million people Worldwide struggling with symptoms months or years after first falling ill with COVID-19. Doctors and scientists don’t fully understand this multi-system condition but a new wave of research is underway. Prof. Resia Pretorius and Prof. Douglas Kell were the first to discover unusual microclots in the blood of people with long COVID. The microclots are thought to cause symptoms by impeding blood and oxygen flow to the body’s organs and tissues. RAZOR’s Emma Keeling travels to Clinic St. George in Germany to meet Dr. Beata Jaeger and learn more about an experimental treatment given to long COVID patients to clear the blood of microclots. Back in the UK Emma meets Dr. Asad Khan whose whole life has been turned upside down by the condition and is now involved in long COVID research. With millions around the world suffering – more research is urgently needed to better understand this dangerous post viral syndrome.
